HALO
Halozyme TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
HALO Profile
Halozyme Therapeutics, Inc.
A biopharmaceutical company that develops recombinant human enzymes and novel oncology therapies for the tumor microenvironment
12390 El Camino Real, San Diego, California, 92130
--
Halozyme Therapeutics, Inc., founded in 1998 and re-incorporated from Nevada in Delaware in November 2007, is a biopharmaceutical company focused on developing and commercializing innovative therapies that improve patient care. The company's research centers on the extracellular matrix, and the structural network surrounding the cell plays a crucial role in tissue integrity, cell signaling, migration and survival. With extensive expertise accumulated through years of research, Halozyme leverages its deep scientific understanding of ECM to develop new therapeutic methods and drug delivery technologies for this complex and biologically rich environment, aiming to advance the next generation of therapeutic solutions.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
